Description
Vial size: 6 mL. Concentration: CJC 1.5 mg/mL + ipamorelin 2.5 mg/mL. Total per vial: CJC 9 mg + ipamorelin 15 mg (24 mg combined).
CJC/Ipamorelin is a compounded peptide combination studied for its potential role in supporting growth hormone signaling and related physiological processes. Research interest has focused on areas such as recovery, body composition, sleep, physical performance, and healthy aging.
This medication is available only after a comprehensive telehealth evaluation. Patients receive informed consent outlining potential risks, side effects, and the investigational nature of compounded peptide medications.




Reviews
There are no reviews yet.